The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis
Open accessAbstract
Importance: Some uncertainty about the clinical value and dosing of atropine for the treatment of myopia in children remains. Objective: To evaluate the efficacy vs the adverse effects of various doses of atropine in the therapy for myopia in children. Data Sources: Data were obtained from PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials, from inception to April 30, 2016. The reference lists of published reviews and clinicaltrials.gov were searched for additional relevant studies. Key search terms included myopia, refractive errors, and atropine. Only studies published in English were included. Study Selection: Randomized clinical trials and cohort studies that enrolled patients younger than 18 years with myopia who received atropine in at least 1 treatment arm and that reported the annual rate of myopia progression and/or any adverse effects of atropine therapy were included in the analysis. Data Extraction and Synthesis: Two reviewers independently abstracted the data. Heterogeneity was statistically quantified by Q, H, and I2 statistics, and a meta-analysis was performed using the random-effects model. The Cochrane Collaboration 6 aspects of bias and the Newcastle-Ottawa Scale were used to assess the risk for bias. Main Outcomes and Measures: The primary outcome was a difference in efficacy and the presence of adverse effects at different doses of atropine vs control conditions. The secondary outcomes included the differences in adverse effects between Asian and white patients. Results: Nineteen unique studies involving 3137 unique children were included in the analysis. The weighted mean differences between the atropine and control groups in myopia progression were 0.50 diopters (D) per year (95% CI, 0.24-0.76 D per year) for low-dose atropine, 0.57 D per year (95% CI, 0.43-0.71 D per year) for moderate-dose atropine, and 0.62 D per year (95% CI, 0.45-0.79 D per year) for high-dose atropine (P < .001), which translated to a high effect size (Cohen d, 0.97, 1.76, and 1.94, respectively). All doses of atropine, therefore, were equally beneficial with respect to myopia progression (P = .15). High-dose atropine were associated with more adverse effects, such as the 43.1% incidence of photophobia compared with 6.3% for low-dose atropine and 17.8% for moderate-dose atropine (χ22 = 7.05; P = .03). In addition, differences in the incidence of adverse effects between Asian and white patients were not identified (χ21 = 0.81; P = .37 for photophobia). Conclusions and Relevance: This meta-analysis suggests that the efficacy of atropine is dose independent within this range, whereas the adverse effects are dose dependent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050
Holden, B. A., Fricke, T. R., Wilson, D. A., Jong, M., Naidoo, K. S., Sankaridurg, P., Wong, T. Y., Naduvilath, T. J., & Resnikoff, S. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.006 · Cited by 5,500
Statistics corner: A guide to appropriate use of correlation coefficient in medical research.
(2012) · Europe PMC (PubMed Central) · Cited by 4,239
Morgan, I. G., Ohno-Matsui, K., & Saw, S.-M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60272-4 · Cited by 1,871
How to Select, Calculate, and Interpret Effect Sizes
Durlak, J. A. (2009) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsp004 · Cited by 1,446
Outdoor Activity Reduces the Prevalence of Myopia in Children
Rose, K. A., Morgan, I. G., Ip, J., Kifley, A., Huynh, S., Smith, W., & Mitchell, P. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.12.019 · Cited by 1,335
Myopia and associated pathological complications
Saw, S., Gazzard, G., Shih‐Yen, E. C., & Chua, W. (2005) · Ophthalmic and Physiological Optics · doi:10.1111/j.1475-1313.2005.00298.x · Cited by 1,098
He, M., Xiang, F., Zeng, Y., Mai, J., Chen, Q., Zhang, J., Smith, W., Rose, K., & Morgan, I. G. (2015) · JAMA · doi:10.1001/jama.2015.10803 · Cited by 1,076
Dolgin, E. (2015) · Nature · doi:10.1038/519276a · Cited by 967
The complex interactions of retinal, optical and environmental factors in myopia aetiology
Flitcroft, D. I. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.06.004 · Cited by 903
Chia, A., Chua, W.-H., Cheung, Y.-B., Wong, W.-L., Lingham, A., Fong, A., & Tan, D. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.07.031 · Cited by 852
Cited by
Baird, P. N., Saw, S.-M., Lanca, C., Guggenheim, J. A., Smith III, E. L., Zhou, X., Matsui, K.-O., Wu, P.-C., Sankaridurg, P., Chia, A., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00231-4 · Cited by 838
Low-Concentration Atropine for Myopia Progression (LAMP) Study
Yam, J. C., Jiang, Y., Tang, S. M., Law, A. K. P., Chan, J. J., Wong, E., Ko, S. T., Young, A. L., Tham, C. C., Chen, L. J., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.05.029 · Cited by 724
IMI – Interventions for Controlling Myopia Onset and Progression Report
Wildsoet, C. F., Chia, A., Cho, P., Guggenheim, J. A., Polling, J. R., Read, S., Sankaridurg, P., Saw, S.-M., Trier, K., Walline, J. J., et al. (2019) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.18-25958 · Cited by 462
Brennan, N. A., Toubouti, Y. M., Cheng, X., & Bullimore, M. A. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100923 · Cited by 355
A Review of Current Concepts of the Etiology and Treatment of Myopia
Cooper, J., & Tkatchenko, A. V. (2018) · Eye & Contact Lens: Science & Clinical Practice · doi:10.1097/icl.0000000000000499 · Cited by 293
Metadata
- Authors
- Gong, Q., Janowski, M., Luo, M., Wei, H., Chen, B., Yang, G., & Liu, L.
- Venue
- JAMA Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2017-06-01
- Volume
- 135
- Issue
- 6
- Pages
- 624
- ISSN
- 2168-6165 (ISSN-L)
- OpenAlex
- W2611968166
- Cited by
- 288
- References
- 32
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis. https://app.cochat.ai/papers/10.1001/jamaophthalmol.2017.1091
- The paper
- Gong, Q., Janowski, M., Luo, M., Wei, H., Chen, B., Yang, G., & Liu, L. (2017). Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis. JAMA Ophthalmology. https://doi.org/10.1001/jamaophthalmol.2017.1091
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.